Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban PK/PD in Post-Bariatric Surgery Patients
NCT02832947Phase 1Completed
- Sponsor
- Insel Gruppe
- Start
- Feb 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Insel Gruppe. Started Feb 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02832947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832947.